3800
D. S. Giera et al.
PAPER
IR (film): 3344, 2945, 1715, 1656, 1511, 1427, 1366, 1309, 1239,
1215, 1184, 1162, 1094, 982, 917, 818, 784, 760, 715 cm–1.
ized with K2CO3 and then extracted with CH2Cl2 (5 × 10 mL). The
combined organic phases were dried (MgSO4) and the solvent was
removed in vacuo to afford 194 mg (97%, 0.59 mmol) of 5 as a col-
orless oil, which did not require further purification; Rf = 0.2 (Et2O);
[a]D24 +5.7 (c = 1.06, CHCl3).
1H NMR (300 MHz, CDCl3): d = 1.28 (t, J = 7.0 Hz, 3 H,
OCH2CH3), 2.70 (m, 2 H, H-4), 3.70 (s, 3 H, OCH3), 3.78 (s, 1 H,
NH), 4.19 (q, J = 7.0 Hz, 2 H, OCH2CH3), 4.49 (t, J = 6.5 Hz, 1 H,
H-5), 5.93 (dt, J = 15.5, 1.5 Hz, 1 H, H-2), 6.45 (mc, 2 Harom), 6.69
(mc, 2 Harom), 6.89 (dt, J = 15.5, 7.5 Hz, 1 H, H-3), 7.25 (ddd,
J = 8.0, 5.0, 1.0 Hz, 1 Harom), 7.66 (dt, J = 8.0, 2.0 Hz, 1 Harom), 8.51
(dd, J = 5.0, 2.0 Hz, 1 Harom), 8.63 (d, J = 2.0 Hz, 1 Harom).
13C NMR (100 MHz, CDCl3): d = 14.2, 41.0, 55.6, 55.7, 60.5,
114.8, 115.0, 123.7, 124.9, 133.9, 138.2, 140.3, 143.4, 148.6, 148.9,
152.6, 165.8.
HRMS (ESI): m/z calcd for C19H23N2O3 [M + H]+: 327.17032;
found: 327.17011; m/z calcd for C19H22N2O3 + Na [M + Na]+:
349.15226; found: 349.15222; m/z calcd for C38H45N4O6 [2 M +
H]+: 653.33336; found: 653.33335; m/z calcd for C38H44N4O6 + Na
[2 M + Na]+: 675.31531; found: 675.31519.
IR (film): 3379, 2934, 2832, 1729, 1619, 1578, 1513, 1426, 1384,
1298, 1238, 1181, 1120, 1037, 877, 821, 758, 717, 621, 524 cm–1.
1H NMR (400 MHz, CDCl3): d = 1.24 (t, J = 7.0 Hz, 3 H,
OCH2CH3), 1.67 (m, 1 H, CHH), 1.81 (m, 3 H, CHH, CH2), 2.33 (t,
J = 6.5 Hz, 2 H, H-2), 3.69 (s, 3 H, OCH3), 3.89 (br s, 1 H, NH),
4.12 (q, J = 7.0 Hz, 2 H, OCH2CH3), 4.30 (t, J = 5.0 Hz, H-5), 6.46
(mc, 2 Harom), 6.68 (mc, 2 Harom), 7.23 (dd, J = 8.0, 4.5 Hz, 1 Harom),
7.65 (d, J = 8.0 Hz, 1 Harom), 8.48 (d, J = 4.5 Hz, 1 Harom), 8.60 (s,
1 Harom).
13C NMR (75 MHz, CDCl3): d = 14.2, 21.5, 33.7, 37.9, 55.7, 56.6,
60.4, 114.6, 114.8, 123.6, 133.9, 139.3, 140.9, 148.5, 148.7, 152.2,
173.1.
HRMS (ESI): m/z calcd for C19H25N2O3 [M + H]+: 329.18597;
found: 329.18623; m/z calcd for C19H24N2O3 + Na [M + Na]+:
351.16791; found: 351.16809; m/z calcd for C38H48N4O6 + Na
[2 M + Na]+: 679.34661; found: 679.34633.
(2E,5R)-5-(4-Methoxyphenylamino)-1-(piperidin-1-yl)-5-(pyri-
din-3-yl)pent-2-en-1-one (4b)
An oven-dried, 10 mL flask containing a solution of N-p-methoxy-
phenylnicotinimine (1a; 42.4 mg 0.20 mmol, 1.0 equiv) and chiral
phosphoric acid 3b (1.70 mg, 0.002 mmol, 0.01 equiv) in a freshly
prepared solvent mixture of i-PrOH, t-BuOH, and 2-methylbutan-2-
ol in H2O (1:1:1 and 1.0 equiv H2O, 2 mL) was cooled to –30 °C.
3-[(2S)-1-(4-Methoxyphenyl)piperidin-2-yl]pyridine (6) and
(5S)-5-(4-Methoxyphenylamino)-5-(pyridin-3-yl)pentan-1-ol
(7)
After
1 min, (Z)-1-[1-(tert-butyldimethylsilyloxy)buta-1,3-di-
A flame-dried 50 mL flask containing a solution of 5 (75.0 mg, 0.23
mmol, 1.0 equiv) in anhyd THF (25 mL) was cooled to –60 °C.
DIBAL-H (0.73 mL, 1 M solution in hexane, 0.73 mmol, 3.2 equiv)
was added dropwise and the resulting solution was stirred for 1 h at
–60 °C. The reaction was quenched by the addition of sat. aq Roch-
elle salt (15 mL), and the mixture was allowed to warm to r.t. After
30 min, the mixture was diluted with H2O (30 mL) and extracted
with CH2Cl2 (5 × 10 mL). The combined organic phases were dried
(MgSO4) and the solvent was removed in vacuo. The residue was
purified by silica gel chromatography (EtOAc–PE, 1:1 → 1:0) to af-
ford 40.0 mg (65%, 0.15 mmol) of 6 and 10.0 mg (15%, 0.035
mmol) of 7, both as colorless oils.
enyl]piperidine (2b; 160 mg, 0.60 mmol, 3.0 equiv) was added drop-
wise. The resulting mixture was stirred rapidly for 36 h at –30 °C
whereupon the solvent was removed in vacuo. The residue was pu-
rified by silica gel chromatography (Et2O–EtOAc, 3:1) to afford
66 mg (90%; 88% ee) 4b as a colorless oil; Rf = 0.1 (Et2O–EtOAc,
3:1); [a]D24 –24.0 (c = 1.00, CHCl3).
HPLC: Chiralcel OD column, solvent: n-hexane–i-PrOH (4:1),
flow rate: 1.0 mL/min, UV detection at 250 nm, major enantiomer
tR = 34.3 min (4b), minor enantiomer tR = 53.9 min (ent-4b).
IR (film): 3329, 2997, 2936, 2855, 1657, 1606, 1512, 1442, 1384,
1238, 1180, 1139, 1125, 1037, 975, 852, 821, 755, 717, 665, 621,
524 cm–1.
1H NMR (300 MHz, CDCl3): d = 1.54 (m, 4 H, CH2), 1.63 (m, 2 H,
CH2), 2.70 (m, 2 H, H-4), 3.37 (m, 2 H, NCH2), 3.57 (m, 2 H,
NCH2), 3.69 (s, 3 H, OCH3), 3.84 (br s, 1 H, NH), 4.48 (t, J = 6.5
Hz, 1 H, H-5), 6.29 (dt, J = 15.0, 1.5 Hz, 1 H, H-2), 6.44 (mc, 2
6
Rf (Et2O) = 0.3; [a]D24 +39.6 (c = 1.52, CHCl3).
IR (film): 2933, 2853, 2720, 1876, 1674, 1578, 1510, 1425, 1385,
1326, 1245, 1182, 1103, 1036, 933, 900, 877, 830, 803, 715, 640,
619, 578, 558, 535 cm–1.
Harom), 6.68 (mc, 2 Harom), 6.74 (dt, J = 15.0, 7.5 Hz, 1 H, H-3), 7.23
(dd, J = 8.0, 5.0 Hz, 1 Harom), 7.66 (dt, J = 8.0, 2.0 Hz, 1 Harom),
8.49 (dd, J = 5.0, 2.0 Hz, 1 Harom), 8.63 (d, J = 2.0 Hz, 1 Harom).
13C NMR (100 MHz, CDCl3): d = 24.5, 25.5, 26.6, 41.3, 43.1, 46.9,
55.7, 55.7, 114.8, 115.0, 123.6, 124.3, 134.1, 138.5, 139.4, 140.5,
148.6, 148.7, 152.5, 164.6.
HRMS (ESI): m/z calcd for C22H28N3O2 [M + H]+: 366.21760;
found: 366.21730; m/z calcd for C22H27N3O2 + Na [M + Na]+:
388.19955; found: 388.19934; m/z calcd for C44H55N6O4 [2 M +
H]+: 731.42793; found: 731.42740; m/z calcd for C44H55N6O4 + Na
[2 M + Na]+: 753.40988; found: 753.40932.
1H NMR (300 MHz, CDCl3): d = 1.44–1.57 (m, 1 H, H-4a), 1.64–
1.94 (m, 5 H, H-3, H-4b, H-5), 2.82 (ddd, J = 12.0, 10.0, 4.0 Hz, 1
H, H-6a), 3.33 (dtd, J = 12.0, 3.0, 1.0 Hz, 1 H, H-6b), 3.67 (s, 3 H,
OCH3), 4.01 (dd, J = 10.0, 2.5, Hz, 1 H, H-2), 6.64 (mc, 2 Harom),
6.89 (mc, 2 Harom), 7.06 (ddd, J = 8.0, 4.5, 0.5 Hz, 1 Harom), 7.55
(ddd, J = 8.0, 2.0, 2.0 Hz, 1 Harom), 8.30 (dd, J = 4.5, 2.0 Hz, 1
Harom), 8.46 (d, J = 2.0 Hz, 1 Harom).
13C NMR (75 MHz, CDCl3,): d = 24.3, 26.4, 36.4, 55.2, 57.1, 62.6,
113.9, 123.2, 124.7, 135.0, 140.1, 145.6, 147.7, 149.3, 155.3.
HRMS (ESI): m/z calcd for C17H21N2O [M + H]+: 269.16484;
found: 269.16483; m/z calcd for C17H20N2O + Na [M + Na]+:
291.14678; found: 291.14675; m/z calcd for C34H40N4O2 + Na
[2 M + Na]+: 559.30435; found: 559.30449.
Ethyl (5S)-5-(4-Methoxyphenylamino)-5-(pyridin-3-yl)penta-
noate (5)10
To a flame-dried 20 mL flask, containing a solution of 4a (200 mg,
0.61 mmol, 1.0 equiv) in degassed anhyd toluene (8 mL) was added
t-BuOH (175mL, 3.0 equiv). After the addition of (BDP)CuH solu-
tion (0.74 mL, 1.0 mM in toluene, prepared following the literature
procedure11), the resulting red solution was stirred at r.t. for 12 h.
The reaction was quenched by addition of sat. aq NH4Cl (6.0 mL).
After dilution with Et2O (30 mL), the solution was extracted with aq
1 N HCl (5 × 10 mL). The combined aqueous phases were neutral-
7
Rf (Et2O) = 0.1; [a]D24 +8.7 (c = 1.60, CHCl3).
IR (film): 3373, 2929, 1592, 1511, 1428, 1385, 1237, 1039, 877,
786, 762, 714 cm–1.
1H NMR (200 MHz, CDCl3): d = 1.38–1.63 (m, 4 H, H-2, H-3),
1.72–1.90 (m, 2 H, H-4), 3.63 (t, J = 6.0 Hz, 2 H, H-1), 3.68 (s, 3
Synthesis 2009, No. 22, 3797–3802 © Thieme Stuttgart · New York